http://www.innomedica.fi/Innomedica Ltd. Innomedica Ltd. RSS News & Events Feed0768d615085a25410d27d1ed7bb9791ehttp://www.innomedica.fi/eng/news__events//?nid=103Thu, 10 May 2012 11:20:00 +0300 Anna Kalmi and Mr Noro will attend the partnering meeting in Boston. The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. More information about the event at: http://convention.bio.org/ Please contact anna.kalmi a innomedica.fi to make an appointment or for more information. Mirva.Tamppinen@innomedica.fi2f613c5e26ca04ce208ce8ab84a8e4e5http://www.innomedica.fi/eng/news__events//?nid=102Fri, 4 May 2012 08:30:00 +0300 Innomedica’s Solveig Sjöblom will give a speech on How to describe project impact and management in a competitive proposal at the Focus on Health Research EU Funding –seminar in Helsinki 8 May 2012. For more information: Mirva.Tamppinen@innomedica.fi4281181044ec873221d436f5ea8b948ahttp://www.innomedica.fi/eng/news__events//?nid=101Fri, 13 Apr 2012 09:00:00 +0300 Matti Juvonen will attend analytica 2012 exhibition in Munich on 17-20 April 2012. analytica is the world’s biggest major fair for the areas of analysis, laboratory technology and biotechnology. More information about the event at: Should you want to meet with Matti, please call +358 40 5289784 or contact by e-mail matti.juvonen a innomedica.fi. Mirva.Tamppinen@innomedica.fi395997b8fc6e1f86fb7fdfabe7ce1326http://www.innomedica.fi/eng/news__events//?nid=100Wed, 11 Apr 2012 16:00:00 +0300 EU launched its strategy and action plan for a sustainable bioeconomy in mid-March 2012. This means investments in sustainable production and exploitation of renewable raw materials as alternative energy and carbon sources. What does it mean to the industry? Solveig.Sjoblom@innomedica.fia7ca9db1719c69058a73fc10d434b593http://www.innomedica.fi/eng/news__events//?nid=99Thu, 15 Mar 2012 10:00:00 +0200 Tanja Dowe will attend the HealthPort scouting and matchmaking workshop in Tallinn, Estonia 20 March 2012. Tanja will also give a speech in the event about licensing and distribution in life sciences. More information about the event at: http://www.biotech.ee/ Please contact tanja.dowe a innomedica.fi to make an appointment or for more information. Mirva.Tamppinen@innomedica.fi6918631c96a1aecc10f77319c28c14d6http://www.innomedica.fi/eng/news__events//?nid=98Tue, 13 Mar 2012 11:00:00 +0200 The Pharmaceutical market in Japan grew 6.9% in 2011 to 115 billion USD. Anna.Kalmi@innomedica.fi5938c72229610944dd0c1799ac6ef796http://www.innomedica.fi/eng/news__events//?nid=97Wed, 7 Mar 2012 14:00:00 +0200Anna Kalmi and Tanja Dowe will attend the partnering meeting in Sweden. Tanja will also give a speech in the event. Topic of the speech is "Turning IPR into cash: Successful licensing & distribution strategies for Japan". Top international investors, life science professionals and stakeholders from regions with strong growth and development meet the best Life Science investment and business opportunities Scandinavia has to offer. More information about the event at: Please contact anna.kalmi a innomedica.fi to make an appointment or for more information.Mirva.Tamppinen@innomedica.fi1b9e3c364b240d578e6984d14ea79222http://www.innomedica.fi/eng/news__events//?nid=96Fri, 2 Mar 2012 13:00:00 +0200Anna Kalmi will attend the partnering meeting in Amsterdam. BIO-Europe Spring® attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. More information about the event at: Please contact anna.kalmi a innomedica.fi to make an appointment or for more information. Mirva.Tamppinen@innomedica.ficde16cb668e0da607b7932ecbc477da1http://www.innomedica.fi/eng/news__events//?nid=95Thu, 1 Mar 2012 13:00:00 +0200 It is said that about every fourth Japanese person suffers from pollen allergy. There are over 60 types of pollens in Japan causing allergic conditions and many people get allergies from several pollens, but about 80 % of the pollen allergy is due to Japanese cedar. The massive plantation of cedar trees since 1960’s has dramatically increased this allergy type in Japan. () The pollen allergy related market is very large and the peak time is February to March. The market of treatment and relief products of pollen allergy is said to be over 50 billion JPY (close to 500 million euro). It is said that pollen allergy related product market size exceeds 150 billion JPY. The economic impacts are considerable since the major part of pollen allergy patients are 20-60 years and this allergy is affecting on their daily productivity. anna.kalmi@innomedica.fi064e76e8af6ba5bc9baef66ff3df506bhttp://www.innomedica.fi/eng/news__events//?nid=94Fri, 3 Feb 2012 12:00:00 +0200 Innomedica’s Anna Kalmi has been selected as evaluator for life science related EU Research Grant applications in 2012. We are very pleased to contribute in the development of life sciences in Europe.Mirva.Tamppinen@innomedica.fi